Introduction
Over the past 20 years, self-report instruments have been used for the assessment of quality-of-life in patients diagnosed with HIV/AIDS (Bozzette, Hays, Berry, & Kanouse, 1994; Cleary et al., 1993; Gifford, Shively, Bormann, Cutler, & Bozzette, 1998; Lenderking, Testa, Katzenstein, & Hammer, 1997; Nokes, Wheeler, & Kendrew, 1994; Whalen, Antani, Carey, & Landefeld, 1994) . Early in the HIV/AIDS epidemic, several researchers adopted the modular approach to quality-of-life assessments, treating each domain as a separate module (Lenderking et al., 1997) . Generic measures had the advantage of enabling comparisons across different diseases, while specific measures had the sensitivity to detect smaller but clinically meaningful changes (Cleary et al., 1993; Hays & Shapiro, 1992) . Specific to the domain symptom distress, an instrument was designed and validated to identify perceived individual symptoms reported by HIV infected patients (Justice, Holmes, et al., 2001) , known as the HIV Symptom Distress Module (SDM). The construct distress, in an HIV population, is characterized by phenomena such as fatigue/low energy, fevers, dizziness, tingling/hand/foot pain, memory loss, nausea/vomiting, diarrhea, depression, anxiety, sleep problems, skin problems, cough/ shortness of breath, headache, appetite loss, bloating/ gas, muscle/joint pain, sexual problems, weight gain weight loss, and hair loss. Presently, this 20-item SDM is widely incorporated as part of the battery of selfreport tools used in clinical studies, with the intended purpose to improve the measurement of symptoms for clinical management, patient-oriented research and adverse drug reactions (Justice, Chang, Rabeneck, & Zackin, 2001) .
Due to interest among clinical trial researchers to report on overall HIV symptom phenomena or clinically relevant groups of HIV symptoms, a summative rating scale for the 20-item SDM has been developed, called the HIV symptom distress scale (SDS). Its utility will most likely benefit HIV clinician/ researchers measuring patient-reported outcomes in comparative HIV trials. Thus, the primary aim of this article is to describe the validation of the SDS and report on its factor structure and psychometric properties examined across sociodemographic groups.
Methods

Data source and data collection
This is a secondary data analysis of a cross-sectional subset of the Collaborations in HIV Outcomes Research US Cohort (CHORUS), which is a population-based observational study designed to follow the clinical and epidemiological outcomes of adults with HIV infection in the US (Becker et al., 2001) . Through the use of an electronic medical record, the project received real-time data collected during routine medical visits. Beginning in August 1997 through 2005, participating physicians offered the opportunity to participate in the project to all of their HIV positive patients who were 18 years of age and older. Information captured at every clinic visit are medical history, physical assessment and plan, medications, laboratories, procedures, and demographics, which has been described in detail elsewhere (Becker et al., 2001; Marc, Zerden, Ferrando, & Testa, 2011) . Quality of life (SF-12 and SF-36 (Gandek et al., 1998; Ware & Sherbourne, 1992) and the 20-item HIV SDM (Justice, Holmes, et al., 2001) ) were captured through patient-completed questionnaires every 6 months. A proportion of the study participants are foreign born and were administered a Haitian-Creole and Spanish language versions of these instruments.
Study inclusion criteria
As of September 2005, a total of 9197 patients consented to participate in CHORUS. Among this population, 5521 participants met the criteria for inclusion into a study focused on HIV quality of life, which created this subset of CHORUS (Marc et al., 2007) . Inclusion criteria required that subjects have (1) a valid baseline SDM completed, with (2) an SF-12 or SF-36 completed on the same day. A valid SDM was defined as one with all the items endorsed, or an instrument with only positive answers (response 01Á4) indicated. A valid SF-12 was defined as one with at least half of the questions answered to be scored. For patients with an SF-36, only the subset of SF-12 questions was used for the analysis and was scored according to the algorithm for SF-12 (Gandek et al., 1998; Ware & Sherbourne, 1992) .
Study population
Participants in this subset of CHORUS (N 05521) are predominately male (88.6%) with primary mode of HIV transmission reported as homosexual/bisexual exposure (75.5%) ( Table 1 ). The median age is 43 years (SD98.7), and median values for baseline immune parameters are 429 CD4 cells/ml and 2.6 for HIV log 10 RNA copies/ml. This population is ethnically diverse with representation among non-Hispanic White (70.7%), African-American (17.6%), and Hispanic (7.8%) participants.
Ethics
The CHORUS project received Independent Review Board approval at Vanderbilt University (Nashville, TN), the Mount Sinai School of Medicine (New York, NY), and Copernicus Group IRB (Cary, NC), described elsewhere (Becker et al., 2001) . This secondary analysis was approved by the Institutional Review Board of the Weill Medical College of Cornell University.
Measures
HIV symptom distress module
The 20-item SDM (Justice, Holmes et al., 2001 ) uses a rating scale from 0 to 4 points. Study participants were asked to rate the degree of bother they experienced for each symptom during the prior two weeks (''0 0do not have symptom,'' ''1 0have symptom, but no bother,'' ''20have symptom, little bother,'' ''30have symptom, bother,'' ''4 0 have symptom, bothers me a lot'') (a higher score indicating greater symptom distress). Based on the inclusion criteria and coding algorithm for this data-set, all 20-items have a response endorsed. Imputations were not performed on missing SDM data. If patients did not respond, this was interpreted as ''never experiencing'' the symptom and coded as ''0.''
HIV symptom distress scale
Responses for the 20-item SDM were transformed using a range of 0Á100, maintaining the order of the (Spector, 1992) . Consistent with the name of the instrument a higher score indicates greater symptom distress (Table 2) .
SF-12
The construction of the SF-12 was based on a pool of items developed as part of the Medical Outcomes Study (Wu, Hays, Kelly, Malitz, & Bozzette, 1997) , and there is substantial evidence for its reliability, construct and predictive validity, and responsiveness (Delate & Coons, 2000; Gandek et al., 1998; Ware & Sherbourne, 1992) . The scale is scored on a 0Á100 scale (a higher score indicates better health), with physical and mental health subscales (Ware, Kosinshi, & Keller, 1995) .
Sociodemographic variables
Educational level was categorized as a five-level ordinal variable: less than high school (1); high school (2); some college (3), college graduate (4), or graduate (5). Race/ethnicity was categorized as a four-level nominal categorical variable: White (1), Black (2), Hispanic (3), and Other (4).
Statistical analysis Descriptive statistics
Univariate statistics were generated, and ceiling/floor effects were considered substantial, if ]20% of subjects scored at the upper-most or bottom-most end of the scale (Testa & Nackley, 1994) . Internal consistency reliability was assessed using Cronbach's alpha (DeVellis, 2003) . The method of known-groups comparisons (Spector, 1992 ) was used to evaluate construct validity to determine the extent to which the SDS score was able to discriminate between patients differing clinically according to their immune parameters (HIV disease severity measured with baseline CD4 and HIV viral load). A test for trend was used to examine construct validity across the ordered groups for HIV viral load and CD4 counts. Between group comparisons were performed across sociodemographics using two tailed t-tests for continuous variables and chi-square for tests of proportions. The alpha-level used for determining significance was 0.05. Software programs used to manage and analyze the data included STATA (CCISD-CECI, 2005), SPSS (2001), and EXCEL (Microsoft Corporation, 2000) .
Factor analysis and model testing
Exploratory and confirmatory factor analysis (CFA) was performed to evaluate unidimensionality and the factor structure of the CHORUS symptom distress data. Exploratory factor analysis accounts for the correlation structure among the observed variables. The method of principal component analysis was used to identify the unobservable ''latent'' factors that underlie or explain the set of observed variables (Coste, Bouee, Ecosse, Leple`ge, & Pouchot, 2005; Nunnally, 1978; Streiner & Norman, 1989) . A screen plot of the positive eigenvalues of the adjusted correlation matrix was generated to determine if one or two factors accounted for most of the common variances among the 20 items. Confirmatory factor analysis was used to determine the number and nature of the different constructs measured by the instrument. The analysis involved validating certain a-priori hypotheses and its anticipated relationships between the observed and latent variables (Lenderking et al., 1997; Whalen et al., 1994) . The hypotheses purport that the symptoms represent a single domain of health for HIV-infected patients Á specifically, the underlying construct of symptom distress.
As the original response choices for the SDM are ordinal and polychotomous in nature ranging from (0 to 4), PRELIS software was used to calculate polychoric correlations accounting for the ordinality of items (Byrne, 1998) . LISREL analysis was then conducted using the polychoric correlations obtained using PRELIS (Jo¨reskog & So¨rbom, 1998) .
The factor analysis included all 20 items on the observations with full data. For the one-factor model, the structure was specified with one latent variable (factor) according to the corresponding observed variables (items). The two-factor model specified two latent variables. Model fit was evaluated primarily with descriptive fit statistics, incremental fits, and errors of approximation (Bentler & Bonnet, 1980; Browne & Cudeck, 1993; Kline, 2004) .
Results
Scale statistics and reliability
Univariate statistics show a mean score ( x 029.5) on a 0Á100-point scale (higher score indicating greater symptom distress). There were no ceiling or floor effects observed, with 4.1% (N 0224) of the study population having a minimum score of 0, and 0.1% with a maximum score of 100; with a 00.92 for the summary measure, confirming a high level of internal consistency. The reliability coefficient suggests that a large proportion of the scale's total variance is attributed to a common source. A stratified analysis across select sociodemographic groups (i.e., age, educational attainment, gender, and race/ethnicity) was performed to assess representative reliability of the new summary measure, showing internal consistency ranging from a 00.85 to a 00.93 across these groups.
Construct validity
Using a test for trend results suggest a statistically significant monotonic relationship between the SDS score, HIV viral load, and CD4 counts. As the scale score increases suggesting greater HIV symptom distress, HIV-1 viral load significantly increases (Z 0 8.54, p B0.001), even after adjusting for age and baseline measures of CD4 cells/ml, duration of antiretroviral therapy (ART), exposure to ART and AIDS defining event (Table 3) . Conversely, a statistically significant inverse monotonic relationship is observed with CD4 counts (Z 0(13.15, p B0.001), controlling for age and baseline measures of HIV log 10 RNA, duration of ART, exposure to ART and AIDS defining event.
Sociodemographic characteristics Gender
Examining the crude data, male study participants reported significantly lower symptom distress scores ( x 028.8) compared to female participants ( x 035.5). This remained statistically significant (p B0.001) even after adjusting for age and baseline measures of HIV log 10 RNA, CD4 cells/ml, duration of ART, exposure to ART, and AIDS-defining event (Table 4 ). 
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Race/ethnicity
Black study participants were less likely to endorse items indicative of bothersome symptoms, compared to White participants, even when the severity of their HIV disease was greater. The mean symptom distress score for Black participants ( x028.5) was statistically significantly lower when compared to White ( x029.8, p00 .002) and Hispanic study participants ( x 029.2; p 00.02). However, this finding was unexpected because Black participants had greater severity of HIV disease at baseline when compared to White participants. The mean baseline viral load for Blacks compared to Whites was statistically significantly higher (B_ x 03.27 copies/ml; W_ x02.91 copies/ml; p50.001), and mean CD4 counts were statistically significantly lower (B_ x0410/ml; W_ x 0488 cells/ml; p 50.001). These observed differences persisted even after adjusting for age, baseline measures of HIV-1 viral load, CD4, duration of ART, exposure to ART, and AIDS-defining event.
Educational attainment
In a crude model, individuals with lower levels of education reported greater bothersome symptoms. Using a multivariate linear regression model, this association remained statistically significant (N 03267, b 0(2.19; F 042.30 (73,259) ; pB0.001) even after adjusting for age, gender, race, and baseline measures of HIV log10 RNA, CD4 count, duration of ART, exposure to ART, and AIDS-defining event (Table 4 ).
Exploratory and confirmatory factor analysis
Results from the initial estimates of the principal component analysis suggest that the first common Adjusting for age and baseline measures. Notes: HIV-1 RNA viral load results were closest to baseline, defined as 0Á90 days prior to baseline log transformed, continuous. CD4 results were closest to baseline, defined as 0Á90 days prior to baseline (cells/ml), continuous. Duration of ART prior to baseline (months), (continuous, naı¨ve patients have zero months). Baseline exposure to antiretroviral therapy is defined as naı¨ve to ART, ART-experienced, and currently on therapy, or ART-experienced and not currently on therapy. AIDS-defining event (clinical diagnosis) at baseline, dichotomous (00no, 1 0yes).
factor is associated with an eigenvalue of 7.52, which accounts for 37.6% of the proportion of the variance in the total communality. Treating the variables as ordinal data, two out of four fit indexes were greater than 0.90 (goodness-of-fit [GFI] 00.83, adjusted goodness-of-fit [AGFI] 00.80, normed fit index [NFI] 00.98, and non-NFI [NNFI] 00.98) for the one-factor model. The root mean square error of approximation suggests an acceptable fit (RMSEA 00.07, [90% CI 0.07 Á 0.07]); with the Chi-square Corrected for Non-normality (x 2 02672.69; p 00.0) (Figure 1 ). When the screen plot of eigenvalues was generated, results showed a clear drop from the first factor to the second, which supports the hypothesis that most questions are related to a single common factor symptom distress. A two-factor confirmatory analysis was then performed using maximum likelihood estimation procedures. Results suggest that two factors are associated with 41.4% of the variance accounted for in the total communality.
Comparing the RMSEA between the one-factor and two-factor CFA model using polychoric correlations, we found the two-factor model a better fit, with two of four fit indexes greater than 0.90 (i.e., GFI 00.88, AGFI00.85, NFI 00.99, and NNFI00.99). Here, the root mean square error of approximation suggests an acceptable fit with the variables treated as ordered categories (RMSEA 0 0.06, [90% CI 0.06 Á 0.06]) ( Figure 2) , with the Satorra Bentler Scaled Chi-square (x 2 03274.20; p00.0) and Chi-square Corrected for Non-normality (x 2 02271.52; p 00.0). From this analysis, two primary factors emerged, referred to as mental and physical symptom distress, reflecting clinically relevant groups of symptoms. The items for depression, anxiety, and insomnia loaded on the mental factor, and all other items loaded on the physical factor.
Statistical properties of the symptom distress subscales
Results from univariate statistics show the median score equal to 41.67 (SD930.4) for the mental subscale and 23.5 (SD921.0) for the physical subscale. There are no ceiling or floor effects for either, and a 00.81 and a 00.90, respectively. Pearson correlations show a statistically significant relationship between the two ( r 00.70; pB0.001).
Comparison of SF-12 and symptom distress subscales
A comparison of the SDS to the SF-12 confirms that the subscales for both instruments have a statistically significant inverse association (r mental 0(0.7331, p B0.001; (r physical 0(0.6550, pB0.001), respectively.
Limitations
There are several limitations to this study, specifically three types of missing data in this subset of CHORUS: (1) Unendorsed items on the SDM were set to ''0'' with the assumption that respondents who failed to endorse did not experience a symptom; (2) there is educational information coded as unknown or missing; and (3) although non-English instruments were administered in Haitian-Creole and Spanish a variable for ''language version'' is not available in CHORUS.
Unanswered questions on the symptom distress module
There is no way to distinguish whether the unanswered questions resulted from the patient failing to endorse the item, or that the patient did not experience the symptom. As such, descriptive and exploratory factor analyses were rerun on the data recoding all unanswered questions that were set to ''0'' (I do not have this symptom) reset as ''missing.'' This was done to determine if the factor structure of the data would change.
First, the pattern of missing data for each of the 20 items was evaluated to examine whether unendorsed items were systematic in the order of appearance in the SDM. Results confirm that the proportion of patients not answering the question did not increase for items appearing at the lower positions of the instrument.
A polychoric exploratory factor analysis was performed using M-Plus software (Muthe´n & Muthe´n, 2007) assuming missing at random (MAR) for unanswered questions. MAR means that the missing data are not related to the value of the variables in the SDM, though they may be related to the underlying factors of the SDS. Results show practically the same factor structure as that obtained when unanswered questions were coded ''0'' (do not have the symptom). Both sets of analyses support a correlated second-order factor model with subscales related to mental and physical HIV symptom distress.
Missing educational data
A sensitivity analysis was performed to determine whether subjects with unknown or missing educational information (N 0305 combined) differed in any way from those who reported educational milestones, across age, race, gender, or immune parameters. Ad hoc analyses showed that participants AIDS Care 1437 with this type of missing data did not differ significantly from their counterparts across sociodemographic characteristics. However, participants with missing educational information had greater severity of disease reporting a statistically higher mean baseline log HIV viral load ( x03.2391.17; N 0157; df03706; t 00.004) than their counterparts reporting educational milestones ( x 02.9491.24; N 03551). 
Missing language version
A limitation of the reliability analyses is that the ''language version'' was not collected as part of the original CHORUS data-set, and information on the translation method was not provided with this copy of the data-set. Therefore, all versions of the instrument have been evaluated as part of the psychometric analyses. Due to the fact that information on country of birth was available for 69.1% (N 03744) of the study participants, a sensitivity analysis excluded all foreign-born (N 0308) to assess Cronbach's alpha. Findings showed that the reliability of the summary measure remained unchanged at a 00.92 for the American-born study participants (N 03436). 
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Discussion
The greatest utility of the HIV SDS is to clinician/ researchers involved in comparative clinical trials measuring improvement, or decline of HIV symptom distress or clinically relevant groups of symptoms in an HIV-infected population. In order for a clinical measure to be useful, it must be sensible, reliable, and valid (Enders, 2006) .
First, the SDS is sensible because it is clinically applicable, easily understood, and easy to score. Second, the SDS is reliable as demonstrated by the high internal consistency of the overall measure, indicating that the symptoms are related to a single underlying construct. SEM supports a correlated second-order factor model with subscales related to mental and physical HIV symptom distress. Third, study findings establish the validity of the SDS, which significantly discriminates clinical differences across baseline measures of HIV-1 viral load and CD4. Fourth, the SDS detects statistical differences between self-reports from diverse sociodemographic groups, which is consistent with other literature showing that women with HIV/AIDS report substantially poorer health than men in several HRQOL domains (Mrus, Williams, Tsevat, Cohn, & Wu, 2005; Wu, Revicki, Jacobson, & Malitz, 1997) ; persons with lower educational levels report poorer HIV qualityof-life than there more educated counterparts (Worthington & Krentz, 2005) ; and Black participants have greater severity of clinical disease than Whites (Raczynski et al., 1994; Sarma et al., 2003) . Finally, future comparative HIV trials should anchor the SDS to clinical results and/or compare the SDS to scores of other health status instruments that measure distress. This strategy will help to interpret the meaning of the SDS and help to establish cut-off scores for HIV clinical distress across studies.
